Items where authors include "Flynn, R."
Article
Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370
Tate, K. orcid.org/0000-0002-3711-7515, Penconek, T., Booth, A. orcid.org/0000-0003-4808-3880 et al. (7 more authors) (2024) Contextually appropriate nurse staffing models: a realist review protocol. BMJ Open, 14 (5). e082883. ISSN 2044-6055
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587
Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736
Proceedings Paper
Flynn, R. and Ragni, A. orcid.org/0000-0003-0634-4456 (2023) Leveraging cross-utterance context for ASR decoding. In: Proceedings of Interspeech 2023. INTERSPEECH 2023, 20-24 Aug 2024, Dublin, Ireland. ISCA - International Speech Communication Association , pp. 1359-1363.
Vincent, S., Flynn, R. and Scarton, C. orcid.org/0000-0002-0103-4072 (2023) MTCue: learning zero-shot control of extra-textual attributes by leveraging unstructured context in neural machine translation. In: Findings of the Association for Computational Linguistics: ACL 2023. Findings of the Association for Computational Linguistics: ACL 2023, 09-14 Jul 2023, Toronto, Canada. Association for Computational Linguistics , pp. 8210-8226. ISBN 9781959429623
Preprint
Flynn, R. and Ragni, A. orcid.org/0000-0003-0634-4456 (2023) How much context does my attention-based ASR system need? [Preprint] (Submitted)